<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD01470000_1</Organism_ID>
  <Organism>HIV-1</Organism>
  <Organism_Latin>Human immunodeficiency virus type 1</Organism_Latin>
  <UniProt_ID>O90786</UniProt_ID>
  <Seq_Length>99</Seq_Length>
  <Molecule_Weight>10749</Molecule_Weight>
  <Pfam_ID>PF00077:RVP</Pfam_ID>
  <Allosteric_Activator_Count>4</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>168</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>HIV-1 PR</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile.</Detail>
      <Keyword>Aspartic-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004190</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPQMIGGIGGFIKVRQYDQIQVDICGHKAIGTVLVGPTPVNIIGRNLLTXIGCTLNF</Protein_Seq>
    <DNA_Seq>CCTCAGGTCACTCTTTGGCAACGACCCCTCGTCACAATAAAAATAGGAGGGCAACTAAAGGAAGCTCTATTAGATACAGGAGCAGATGATACAGTATTAGAAGAAATGAGTTTGCCAGGAAGATGGAAACCACAAATGATAGGGGGAATTGGAGGTTTTATCAAAGTAAGACAGTATGATCAGATACAGGTAGACATCTGTGGACATAAAGCTATAGGTACAGTATTAGTAGGACCTACACCTGTCAACATAATTGGAAGAAACCTGTTGACTCAMATTGGTTGCACTTTAAATTTT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Unknown</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Unknown</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>HIV-1 protease</Gene_Name>
    <Genbank_ACCN>AJ010723</Genbank_ACCN>
    <Protein_ACCN>CAA09321</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/nuccore/3549935?report=genbank</Gene_URL>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>HIV-1 PROTEASE INHIBITORS CONTAINING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMIC WITH IMPROVED CELL-BASED ANTIVIRAL ACTIVITY</PDB_Title>
      <PDB_ID>2WKZ</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WKZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>METHYL [(1S)-1-({2-[(3S)-3-BENZYL-3-HYDROXY- 4-{[(1S,2R)-2-HYDROXY-2,3-DIHYDRO
-1H-INDEN- 1-YL]AMINO}-4-OXOBUTYL]-2-(4-PYRIDIN-2-YLBENZYL)HYDRAZINO}CARBONYL)
- 2,2-DIMETHYLPROPYL]CARBAMATE</Ligand_Name>
      <PubMed_Title>HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells.</PubMed_Title>
      <Author>Mahalingam AK, et al.</Author>
      <Journal>J Med Chem. 2010 Jan 28;53(2):607-15.</Journal>
      <PubMed_ID>19961222</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV Protease (PR) with inhibitor TL-3 bound, and DMSOs in exo site</PDB_Title>
      <PDB_ID>3KFP</PDB_ID>
      <Resolution>1.77</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KFP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>BENZYL (2S,5S,8S,9R,10R,11S,14S,17S)-8,11- DIBENZYL-9,10-DIHYDROXY-5,14
-DIISOPROPYL- 3,6,13,16-TETRAOXO-4,7,12,15-TETRAAZAOCTADECANE- 2,17-DIYLDICARBAMATE$BETA-MERCAPTOETHANOL $DIMETHYL SULFOXIDE</Ligand_Name>
      <PubMed_Title>Fragment-Based Screen against HIV Protease</PubMed_Title>
      <Author>Perryman AL, et al.</Author>
      <Journal>(2010) Chem.Biol.Drug Des. 75: 257-268</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV Protease (PR) dimer with inhibitor TL-3 bound and fragment 1F1 in the outside/top of flap</PDB_Title>
      <PDB_ID>3KFR</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KFR</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11920004</ASD_Ligand>
      <Ligand_Name>1H-indole-6-carboxylic acid $BENZYL (2S,5S,8S,9R,10R,11S,14S,17S)-8,11- DIBENZYL-9,10-DIHYDROXY-5,14
-DIISOPROPYL- 3,6,13,16-TETRAOXO-4,7,12,15-TETRAAZAOCTADECANE- 2,17-DIYLDICARBAMATE $BETA-MERCAPTOETHANOL</Ligand_Name>
      <PubMed_Title>Fragment-Based Screen against HIV Protease</PubMed_Title>
      <Author>Perryman AL, et al.</Author>
      <Journal>(2010) Chem.Biol.Drug Des. 75: 257-268</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of chemically synthesized [Aib51/51']HIV-1 protease</PDB_Title>
      <PDB_ID>3HDK</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HDK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}- L-norleucyl-L
-glutaminyl-N~5~-[amino(iminio)methyl]- L-ornithinamide</Ligand_Name>
      <PubMed_Title>Hydrogen bonds at the protein-inhibitor interface in the HIV-1 protease / inhibitor complexes probed by total chemical synthesis and X-ray crystallography</PubMed_Title>
      <Author>Torbeev VY, et al.</Author>
      <Journal>To be Published</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Zymogen HGF-beta/MET with Zymogen Activator Peptide ZAP2.3</PDB_Title>
      <PDB_ID>4O3U</PDB_ID>
      <Resolution>3.04</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4O3U</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01470059</ASD_Ligand>
      <PubMed_Title>An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.</PubMed_Title>
      <Author>Landgraf, K.E., et al.</Author>
      <Journal>Nat.Chem.Biol.(2014)10:567-573</Journal>
      <PubMed_ID>24859116</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10265</PDB_Title>
      <PDB_ID>3KDD</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KDD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(4R)-3-[(2S,3S)-3-{[(2,6-difluorophenoxy)acetyl]amino}- 2-hydroxy-4
-phenylbutanoyl]-N-[(1S,2R)-2- hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethyl- 1,3
-thiazolidine-4-carboxamide</Ligand_Name>
      <PubMed_Title>How much binding affinity can be gained by filling a cavity?</PubMed_Title>
      <Author>Kawasaki Y, et al.</Author>
      <Journal>Chem Biol Drug Des. 2010 Feb;75(2):143-51.</Journal>
      <PubMed_ID>20028396</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HIV-1 Protease Complexed with KNI-1689</PDB_Title>
      <PDB_ID>3A2O</PDB_ID>
      <Resolution>0.88</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3A2O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(4R)-3-[(2S,3S)-3-{[(4-amino-2,6-dimethylphenoxy)acetyl]amino}- 2-hydroxy-4
-phenylbutanoyl]-5,5-dimethyl- N-(2-methylprop-2-en-1-yl)-1,3-thiazolidine- 4
-carboxamide</Ligand_Name>
      <PubMed_Title>Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket.</PubMed_Title>
      <Author>Hidaka K, et al.</Author>
      <Journal>J Med Chem. 2009 Dec 10;52(23):7604-17.</Journal>
      <PubMed_ID>19954246</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10074</PDB_Title>
      <PDB_ID>3KDC</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KDC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(4R)-3-[(2S,3S)-3-{[(2,6-dichlorophenoxy)acetyl]amino}- 2-hydroxy-4
-phenylbutanoyl]-N-[(1S,2R)-2- hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethyl- 1,3
-thiazolidine-4-carboxamide</Ligand_Name>
      <PubMed_Title>How much binding affinity can be gained by filling a cavity?</PubMed_Title>
      <Author>Kawasaki Y, et al.</Author>
      <Journal>Chem Biol Drug Des. 2010 Feb;75(2):143-51.</Journal>
      <PubMed_ID>20028396</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of protease inhibitor, AD78 in complex with wild type HIV-1 protease</PDB_Title>
      <PDB_ID>3GI6</PDB_ID>
      <Resolution>1.84</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GI6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(5S)-N-[(1S,2R)-2-Hydroxy-3-[[(4-methoxyphenyl)sulfonyl](2- methylpropyl)amino]
-1-(phenylmethyl)propyl]- 2-oxo-3-[3-(trifluoromethyl)phenyl]-5
-oxazolidinecarboxamide</Ligand_Name>
      <PubMed_Title>Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed to be Robust against Drug Resistance</PubMed_Title>
      <Author>Nalam MNL, et al.</Author>
      <Journal>To be Published</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV Protease (PR) dimer without inhibitor; acetate in exo site</PDB_Title>
      <PDB_ID>3KF1</PDB_ID>
      <Resolution>1.54</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KF1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $BETA-MERCAPTOETHANOL</Ligand_Name>
      <PubMed_Title>Fragment-Based Screen against HIV Protease</PubMed_Title>
      <Author>Perryman AL, et al.</Author>
      <Journal>(2010) Chem.Biol.Drug Des. 75: 257-268</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10006</PDB_Title>
      <PDB_ID>3KDB</PDB_ID>
      <Resolution>1.66</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KDB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(4R)-3-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]amino}- 2-hydroxy-4
-phenylbutanoyl]-N-[(1S,2R)-2- hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethyl- 1,3
-thiazolidine-4-carboxamide</Ligand_Name>
      <PubMed_Title>How much binding affinity can be gained by filling a cavity?</PubMed_Title>
      <Author>Kawasaki Y, et al.</Author>
      <Journal>Chem Biol Drug Des. 2010 Feb;75(2):143-51.</Journal>
      <PubMed_ID>20028396</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of protease inhibitor, KB60 in complex with wild type HIV-1 protease</PDB_Title>
      <PDB_ID>3GI4</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GI4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>5S)-N-[(1S,2R)-3-[(1,3-Benzodioxol-5-ylsulfonyl)(2- methylpropyl)amino]-2
-hydroxy-1-(phenylmethyl)propyl]- 2-oxo-3-[3-(trifluoromethyl)phenyl]-5
-oxazolidinecarboxamide</Ligand_Name>
      <PubMed_Title>Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed to be Robust against Drug Resistance</PubMed_Title>
      <Author>Nalam MNL, et al.</Author>
      <Journal>To be Published</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' [L-Ala51,D-Ala51'] HIV-1 PROTEASE MOLECULE</PDB_Title>
      <PDB_ID>3FSM</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FSM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}- L-norleucyl-L
-glutaminyl-N~5~-[amino(iminio)methyl]- L-ornithinamide</Ligand_Name>
      <PubMed_Title>Correlations of Dynamics with Function in HIV-1 Protease Catalysis</PubMed_Title>
      <Author>Torbeev VY, et al.</Author>
      <Journal>To be Published</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 PROTEASE INHIBITORS CONTAINING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMIC WITH IMPROVED CELL-BASED ANTIVIRAL ACTIVITY</PDB_Title>
      <PDB_ID>2WL0</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WL0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>METHYL [(1S)-1-({2-[(3S)-3-BENZYL-3-HYDROXY- 4-{[(1S,2R)-2-HYDROXY-2,3-DIHYDRO
-1H-INDEN- 1-YL]AMINO}-4-OXOBUTYL]-2-(4-PYRIDIN-2-YLBENZYL)HYDRAZINO}CARBONYL)
- 2,2-DIMETHYLPROPYL]CARBAMATE</Ligand_Name>
      <PubMed_Title>HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells.</PubMed_Title>
      <Author>Mahalingam AK, et al.</Author>
      <Journal>J Med Chem. 2010 Jan 28;53(2):607-15.</Journal>
      <PubMed_ID>19961222</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of N88S mutant HIV-1 Protease</PDB_Title>
      <PDB_ID>3KT5</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KT5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Resistance mechanism revealed by crystal structures of unliganded nelfinavir-resistant HIV-1 protease non-active site mutants N88D and N88S.</PubMed_Title>
      <Author>Bihani SC, et al.</Author>
      <Journal>Biochem Biophys Res Commun. 2009 Nov 13;389(2):295-300.</Journal>
      <PubMed_ID>19720046</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV Protease with fragment 4D9 bound</PDB_Title>
      <PDB_ID>3KF0</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KF0</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11920008</ASD_Ligand>
      <Ligand_Name>BENZYL (2S,5S,8S,9R,10R,11S,14S,17S)-8,11- DIBENZYL-9,10-DIHYDROXY-5,14
-DIISOPROPYL- 3,6,13,16-TETRAOXO-4,7,12,15-TETRAAZAOCTADECANE- 2,17-DIYLDICARBAMATE $(1S,2S)-2-methylcyclohexanol $BETA-MERCAPTOETHANOL $DIMETHYL SULFOXIDE $POTASSIUM ION</Ligand_Name>
      <PubMed_Title>Fragment-Based Screen against HIV Protease</PubMed_Title>
      <Author>Perryman AL, et al.</Author>
      <Journal>(2010) Chem.Biol.Drug Des. 75: 257-268</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of N88D mutant HIV-1 Protease</PDB_Title>
      <PDB_ID>3KT2</PDB_ID>
      <Resolution>1.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KT2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Resistance mechanism revealed by crystal structures of unliganded nelfinavir-resistant HIV-1 protease non-active site mutants N88D and N88S.</PubMed_Title>
      <Author>Bihani SC, et al.</Author>
      <Journal>Biochem Biophys Res Commun. 2009 Nov 13;389(2):295-300.</Journal>
      <PubMed_ID>19720046</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Zymogen HGF-beta/MET with Zymogen Activator Peptide ZAP.14</PDB_Title>
      <PDB_ID>4O3T</PDB_ID>
      <Resolution>2.99</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4O3T</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01470017</ASD_Ligand>
      <PubMed_Title>An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.</PubMed_Title>
      <Author>Landgraf, K.E., et al.</Author>
      <Journal>Nat.Chem.Biol.(2014)10:567-573</Journal>
      <PubMed_ID>24859116</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of protease inhibitor, KB62 in complex with wild type HIV-1 protease</PDB_Title>
      <PDB_ID>3GI5</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GI5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(5S)-3-(3-Acetylphenyl)-N-[(1S,2R)-3-[(1,3- benzodioxol-5-ylsulfonyl)(2
-methylpropyl)amino]- 2-hydroxy-1-(phenylmethyl)propyl]-2-oxo-5- oxazolidinecarboxamide</Ligand_Name>
      <PubMed_Title>Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed to be Robust against Drug Resistance</PubMed_Title>
      <Author>Nalam MNL, et al.</Author>
      <Journal>To be Published</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV Protease (PR) with inhibitor TL-3 and fragment hit 4D9 by soaking</PDB_Title>
      <PDB_ID>3KFN</PDB_ID>
      <Resolution>1.77</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KFN</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11920008</ASD_Ligand>
      <Ligand_Name>BENZYL (2S,5S,8S,9R,10R,11S,14S,17S)-8,11- DIBENZYL-9,10-DIHYDROXY-5,14
-DIISOPROPYL- 3,6,13,16-TETRAOXO-4,7,12,15-TETRAAZAOCTADECANE- 2,17-DIYLDICARBAMATE $(1S,2S)-2-methylcyclohexanol $BETA-MERCAPTOETHANOL $DIMETHYL SULFOXIDE $POTASSIUM ION</Ligand_Name>
      <PubMed_Title>Fragment-Based Screen against HIV Protease</PubMed_Title>
      <Author>Perryman AL, et al.</Author>
      <Journal>(2010) Chem.Biol.Drug Des. 75: 257-268</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of uncomplexed HIV_1 Protease Subtype A</PDB_Title>
      <PDB_ID>3IXO</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3IXO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes</PubMed_Title>
      <Author>Robbins AH, et al.</Author>
      <Journal>(2010) Acta Crystallogr.,Sect.D D66: 233-242</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV Protease (PR) dimer with inhibitor TL-3 bound and fragment 2F4 in the outside/top of flap</PDB_Title>
      <PDB_ID>3KFS</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KFS</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11920006</ASD_Ligand>
      <Ligand_Name>1-benzothiophen-2-ylacetic acid $BENZYL (2S,5S,8S,9R,10R,11S,14S,17S)-8,11- DIBENZYL-9,10-DIHYDROXY-5,14
-DIISOPROPYL- 3,6,13,16-TETRAOXO-4,7,12,15-TETRAAZAOCTADECANE- 2,17-DIYLDICARBAMATE $BETA-MERCAPTOETHANOL $DIMETHYL SULFOXIDE</Ligand_Name>
      <PubMed_Title>Fragment-Based Screen against HIV Protease</PubMed_Title>
      <Author>Perryman AL, et al.</Author>
      <Journal>(2010) Chem.Biol.Drug Des. 75: 257-268</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.if.b.b.b.html</SCOP_URL>
    <CATH_Class>Mainly beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1hiv</CATH_URL>
  </Fold>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.23.16</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/23/16.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD01470001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470017</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470038</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470040</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470042</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470048</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470049</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470052</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470054</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470055</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470056</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470057</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470058</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01470059</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478038</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478042</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478049</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478052</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478054</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478055</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478056</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478058</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478059</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478060</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478061</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478063</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478064</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478065</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478067</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478069</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478070</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478071</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478073</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478074</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478075</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478076</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478077</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478078</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478079</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478080</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478081</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478082</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478083</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478084</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478085</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478086</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478087</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478088</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478089</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478090</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478091</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478092</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478093</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478094</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478095</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478096</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478097</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478099</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478100</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478101</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478102</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478103</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478104</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478105</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478106</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478107</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478108</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478109</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478110</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478111</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478112</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478113</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478114</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478115</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478116</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478118</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478119</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478120</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478121</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478122</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478123</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478124</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01478125</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>